Equities

QuidelOrtho Corp

QuidelOrtho Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)42.50
  • Today's Change0.28 / 0.66%
  • Shares traded902.04k
  • 1 Year change-54.41%
  • Beta0.1615
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 02-May-24
Select bar for recommendation details.
Recommendations02-May-24
Buy0
Outperform3
Hold3
Underperform1
Sell0

Share price forecast in USD

The 5 analysts offering 12 month price targets for Quidelortho Corp have a median target of 60.00, with a high estimate of 81.00 and a low estimate of 40.00. The median estimate represents a 41.18% increase from the last price of 42.50.
High90.6%81.00
Med41.2%60.00
Low-5.9%40.00

Earnings history & estimates in USD

On Feb 13, 2024, Quidelortho Corp reported 4th quarter 2023 earnings of 1.17 per share.
The next earnings announcement is expected on May 08, 2024.
Average growth rate+48.22%
Quidelortho Corp reported annual 2023 earnings of 4.13 per share on Feb 13, 2024.
Average growth rate+117.88%
More ▼

Revenue history & estimates in USD

Quidel Corporation had 4th quarter 2023 revenues of 742.60m. This missed the 796.91m consensus estimate of the 8 analysts following the company. This was 25.91% below the prior year's 4th quarter results.
Average growth rate-3.02%
Quidel Corporation had revenues for the full year 2023 of 3.00bn. This was 8.21% below the prior year's results.
Average growth rate+74.24%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.